Genetic Technologies Investor Presentation and Webinar
Filed with ASX · · 25 pages · English and French
Melbourne, Australia, 28 July 2021: Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), a diversified Genomics and AI driven preventative health business provides the attached presentation and advises that the Company will be providing the following webinar for investors in Australia. Thursday 29 July 2021 at 9:30am AEST/Wednesday 28 July at 7:30pm EST 60-66 Hanover Street www.gtglab
Genetic Technologies Limited on 6ix
In the deck
Earlier from Genetic Technologies
- Genetic Technologies Acquires EasyDNA
- US Patent Office Grants Foundational Pharmacogenomic Patent
- GTG COVID-19 Risk Test launched in USA
- COVID- 19 Risk Test Approved for Commercial Release
- GTG signs 3-year US licence agreement for COVID risk test
Later from Genetic Technologies
- Completion of EasyDNA Acquisition set for global expansion
- Genetic Technologies FY21 Full Year Results
- Presentation to H.C. Wainwright Investment Conference
- GTG delivers material increase in cash receipts
- Momentum Building with Cash Receipts up 112% for Q2 FY22
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies